J Knee Surg 2023; 36(03): 322-328
DOI: 10.1055/s-0041-1733901
Original Article

Effects of Venous Insufficiency in Patients Undergoing Primary Total Knee Arthroplasty: An Analysis of 1.2 Million Patients

Spencer Summers
1   Department of Orthopaedic Surgery and Rehabilitation, University of Miami Health System, Miami, Florida
,
Ramakanth Yakkanti
1   Department of Orthopaedic Surgery and Rehabilitation, University of Miami Health System, Miami, Florida
,
Justin Ocksrider
1   Department of Orthopaedic Surgery and Rehabilitation, University of Miami Health System, Miami, Florida
,
1   Department of Orthopaedic Surgery and Rehabilitation, University of Miami Health System, Miami, Florida
,
Angelo Mannino
2   Department of Orthopaedic Surgery, Maimonides Medical Center, Brooklyn, New York
,
Martin Roche
3   Department of Orthopedic Surgery, Holy Cross Orthopedic Institute, Fort Lauderdale, Florida
,
Victor H. Hernandez
1   Department of Orthopaedic Surgery and Rehabilitation, University of Miami Health System, Miami, Florida
› Institutsangaben
Funding None.

Abstract

Chronic venous insufficiency (CVI) is extraordinarily prevalent in our aging population with over 30 million people in the United States suffering from the disease. There is a paucity of data analyzing the effects of CVI on outcomes following total knee arthroplasty (TKA). The purpose of this study was to utilize a nationwide administrative claims database to determine whether patients with CVI undergoing TKA have higher rates of: (1) in-hospital lengths of stay (LOS); (2) readmission rates; (3) medical complications; (4) implant-related complications; and (5) costs of care compared to controls. Using a nationwide database, we matched patients with CVI undergoing TKA to controls without CVI undergoing TKA in a 1:5 ratio by age, sex, and medical comorbidities associated with CVI. Primary outcomes analyzed within the study included LOS, 90-day readmission rates, 90-day medical complications, 2-year implant-related complications, in addition to 90-day total global episode of care costs. The query yielded 1,265,534 patients with (n = 210,926) and without (n = 1,054,608) CVI undergoing primary TKA. Patients with CVI had significantly longer LOS (4 vs. 3 days, p < 0.0001), higher 90-day readmission rates (20.96 vs. 15.34%; odds ratio [OR]: 1.46, 95% confidence interval [CI]: 1.44–1.48, p < 0.0001), and higher odds of medical complications (2.27 vs. 1.30%; OR: 1.76, 95% CI: 1.70–1.83, p< 0.0001) compared to matched controls. Patients with CVI also had higher odds of periprosthetic joint infections (2.23 vs. 1.03%; OR: 2.18, p < 0.0001) and implant-related complications in general (4.27 vs. 2.17%; OR: 2.01, 95% CI: 1.96–2.06, p < 0.0001). Additionally, patients with CVI had higher total global 90-day episode of care costs ($15,583.07 vs. $14,286.95, p < 0.0001). Patients with CVI undergoing TKA have increased LOS, higher odds of medical and implant complications, and increased costs of care compared to those without CVI. The study can be utilized by orthopaedic surgeons to counsel patients on the potential complications following this procedure. This is a level III, retrospective cohort study.

Supplementary Material



Publikationsverlauf

Eingereicht: 22. September 2020

Angenommen: 21. Juni 2021

Artikel online veröffentlicht:
31. August 2021

© 2021. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • References

  • 1 Criqui MH, Denenberg JO, Bergan J, Langer RD, Fronek A. Risk factors for chronic venous disease: the San Diego Population Study. J Vasc Surg 2007; 46 (02) 331-337
  • 2 Al Shammeri O, AlHamdan N, Al-Hothaly B, Midhet F, Hussain M, Al-Mohaimeed A. Chronic venous insufficiency: prevalence and effect of compression stockings. Int J Health Sci (Qassim) 2014; 8 (03) 231-236
  • 3 Youn YJ, Lee J. Chronic venous insufficiency and varicose veins of the lower extremities. Korean J Intern Med (Korean Assoc Intern Med) 2019; 34 (02) 269-283
  • 4 Beebe-Dimmer JL, Pfeifer JR, Engle JS, Schottenfeld D. The epidemiology of chronic venous insufficiency and varicose veins. Ann Epidemiol 2005; 15 (03) 175-184
  • 5 McArdle M, Hernandez-Vila EA. Management of chronic venous disease. Tex Heart Inst J 2017; 44 (05) 347-349
  • 6 Quarto G, Amato B, Benassai G. et al. Prophylactic GSV surgery in elderly candidates for hip or knee arthroplasty. Open Med (Wars) 2016; 11 (01) 471-476
  • 7 Kranke P, Bennett MH, Martyn-St James M, Schnabel A, Debus SE, Weibel S. Hyperbaric oxygen therapy for chronic wounds. Cochrane Database Syst Rev 2015; 2015 (06) CD004123
  • 8 Dini V, Janowska A, Oranges T, De Pascalis A, Iannone M, Romanelli M. Surrounding skin management in venous leg ulcers: a systematic review. J Tissue Viability 2020; 29 (03) 169-175
  • 9 Zaghloul A, Haddad B, Barksfield R, Davis B. Early complications of surgery in operative treatment of ankle fractures in those over 60: a review of 186 cases. Injury 2014; 45 (04) 780-783
  • 10 Katzel EB, Nayar HS, Davenport MP, Bossert RP, Rubin JP, Gusenoff JA. The influence of preexisting lower extremity edema and venous stasis disease on body contouring outcomes. Ann Plast Surg 2014; 73 (04) 365-370
  • 11 Zhang Y, Jordan JM. Epidemiology of osteoarthritis. Clin Geriatr Med 2010; 26 (03) 355-369
  • 12 Kremers HM, Larson DR, Crowson CS. et al. Prevalence of total hip and knee replacement in the United States. J Bone Jt Surg, Am Vol (CD-ROM Ed) 2014; 97 (17) 1386-1397
  • 13 Güneş S, Şehim K, Cüneyt K, Gökmen D, Küçükdeveci AA. Is there a relationship between venous insufficiency and knee osteoarthritis?. Turk J Phys Med Rehabil 2020; 66 (01) 40-46
  • 14 Cancienne JM, Brockmeier SF, Carson EW, Werner BC. Risk factors for infection after shoulder arthroscopy in a large Medicare population. Am J Sports Med 2018; 46 (04) 809-814
  • 15 Kahn SR, M'Lan CE, Lamping DL, Kurz X, Bérard A, Abenhaim L. Veines Study Group. The influence of venous thromboembolism on quality of life and severity of chronic venous disease. J Thromb Haemost 2004; 2 (12) 2146-2151
  • 16 Bergan JJ, Schmid-Schönbein GW, Smith PDC, Nicolaides AN, Boisseau MR, Eklof B. Chronic venous disease. N Engl J Med 2006; 355 (05) 488-498
  • 17 Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am 2007; 89 (04) 780-785
  • 18 Zhang J, Chen Z, Zheng J, Breusch SJ, Tian J. Risk factors for venous thromboembolism after total hip and total knee arthroplasty: a meta-analysis. Arch Orthop Trauma Surg 2015; 135 (06) 759-772
  • 19 Dua A, Neiva S, Sutherland A. Does previous varicose vein surgery alter deep vein thrombosis risk after lower limb arthroplasty?. Orthop Surg 2012; 4 (04) 222-226
  • 20 Culler SD, Jevsevar DS, Shea KG, Wright KK, Simon AW. The incremental hospital cost and length-of-stay associated with treating adverse events among Medicare beneficiaries undergoing TKA. J Arthroplasty 2015; 30 (01) 19-25
  • 21 Pugely AJ, Martin CT, Gao Y, Belatti DA, Callaghan JJ. Comorbidities in patients undergoing total knee arthroplasty: do they influence hospital costs and length of stay?. Clin Orthop Relat Res 2014; 472 (12) 3943-3950
  • 22 Cram P, Lu X, Kaboli PJ. et al. Clinical characteristics and outcomes of Medicare patients undergoing total hip arthroplasty, 1991-2008. JAMA 2011; 305 (15) 1560-1567
  • 23 Bosco III JA, Karkenny AJ, Hutzler LH, Slover JD, Iorio R. Cost burden of 30-day readmissions following Medicare total hip and knee arthroplasty. J Arthroplasty 2014; 29 (05) 903-905
  • 24 Keeney JA, Nam D, Johnson SR, Nunley RM, Clohisy JC, Barrack RL. The impact of risk reduction initiatives on readmission: THA and TKA readmission rates. J Arthroplasty 2015; 30 (12) 2057-2060
  • 25 Wound Healing Problems in TKA: Just When You Thought it was Over! - ProQuest. Accessed August 21, 2020 at: https://search.proquest.com/docview/203881602?pq-origsite=gscholar&fromopenview=true
  • 26 Radcliff KE, Orozco FR, Quinones D, Rhoades D, Sidhu GS, Ong AC. Preoperative risk stratification reduces the incidence of perioperative complications after total knee arthroplasty. J Arthroplasty 2012; 27 (8, Suppl): 77-80.e1, 8
  • 27 Ruxanda A, Grecu D, Surlin V, Georgescu I, Gugilă I. Lower limb varicosity in patients, with indication for total knee arthroplasty [in Romanian]. Chirurgia (Bucur) 2005; 100 (03) 251-254
  • 28 D'Apuzzo MR, Novicoff WM, Browne JA. The John Insall Award: morbid obesity independently impacts complications, mortality, and resource use after TKA. Clin Orthop Relat Res 2015; 473 (01) 57-63
  • 29 Hashimoto RE, Brodt ED, Skelly AC, Dettori JR. Administrative database studies: goldmine or goose chase?. Evid Based Spine Care J 2014; 5 (02) 74-76
  • 30 Memtsoudis SG, González Della Valle A, Besculides MC, Gaber L, Sculco TP. In-hospital complications and mortality of unilateral, bilateral, and revision TKA: based on an estimate of 4,159,661 discharges. In: Clinical Orthopaedics and Related Research. Vol. 466. New York: Springer; 2008: 2617-2627
  • 31 Medicine Y, Golinvaux N. EliScholar-A Digital Platform for Scholarly Publishing at Yale Limitations of Administrative Databases. In: Orthopaedic Surgery Research: A Study in Obesity and Anemia; 2015. Accessed March 21, 2021 at: http://elischolar.library.yale.edu/ymtdl/1967
  • 32 Vakharia RM, Adams CT, Anoushiravani AA, Ehiorobo JO, Mont MA, Roche MW. Chronic obstructive pulmonary disease is associated with higher rates of venous thromboemboli following primary total knee arthroplasty. J Arthroplasty 2020; 35 (08) 2066-2071.e9
  • 33 Kim J, Seo BS. How to calculate sample size and why. Clin Orthop Surg 2013; 5 (03) 235-242
  • 34 Zhang Y, Hedo R, Rivera A, Rull R, Richardson S, Tu XM. Post hoc power analysis: is it an informative and meaningful analysis?. Gen Psychiatr 2019; 32 (04) e100069
  • 35 Levine M, Ensom MHH. Post hoc power analysis: an idea whose time has passed?. Pharmacotherapy 2001; 21 (04) 405-409
  • 36 Vorhies JS, Wang Y, Herndon JH, Maloney WJ, Huddleston JI. Decreased length of stay after TKA is not associated with increased readmission rates in a national Medicare sample. Clin Orthopaed Related Res 2012; 470: 166-171